{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:16:19Z","timestamp":1770045379871,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81272555"],"award-info":[{"award-number":["81272555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81070327"],"award-info":[{"award-number":["81070327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81071895"],"award-info":[{"award-number":["81071895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30971174"],"award-info":[{"award-number":["30971174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.toxicon.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T12:36:42Z","timestamp":1370435802000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A closer look to botulinum neurotoxin type A-induced analgesia"],"prefix":"10.1016","volume":"71","author":[{"given":"Bao-Lin","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Dong","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.toxicon.2013.05.011_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.toxicon.2009.01.036","article-title":"Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain","volume":"54","author":"Abbott","year":"2009","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.toxicon.2013.05.011_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002508-200503000-00010","article-title":"Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia","volume":"21","author":"Allam","year":"2005","journal-title":"Clin. J. Pain"},{"issue":"10","key":"10.1016\/j.toxicon.2013.05.011_bib3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.pmrj.2011.06.013","article-title":"Emerging concepts in the treatment of myofascial pain: a review of medications, modalities, and needle-based interventions","volume":"3","author":"Annaswamy","year":"2011","journal-title":"PM R"},{"issue":"5","key":"10.1016\/j.toxicon.2013.05.011_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.05.011_bib5","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2011.06.013","article-title":"Updates on the antinociceptive mechanism hypothesis of botulinum toxin A","volume":"17","author":"Aoki","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.toxicon.2013.05.011_bib6","first-page":"201","article-title":"Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain","volume":"46","author":"Bach-Rojecky","year":"2005","journal-title":"Croat. Med. J."},{"issue":"1\u20133","key":"10.1016\/j.toxicon.2013.05.011_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","article-title":"Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection","volume":"633","author":"Bach-Rojecky","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2013.05.011_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10194-003-0049-2","article-title":"Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study","volume":"4","author":"Barrientos","year":"2003","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.toxicon.2013.05.011_bib10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1586\/14737175.7.11.1565","article-title":"Trigeminal neuralgia: for one nerve a multitude of treatments","volume":"7","author":"Cheshire","year":"2007","journal-title":"Expert Rev. Neurother."},{"issue":"11","key":"10.1016\/j.toxicon.2013.05.011_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1726-4901(10)70126-X","article-title":"Therapeutic effects of intra-articular botulinum neurotoxin in advanced knee osteoarthritis","volume":"73","author":"Chou","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"issue":"3","key":"10.1016\/j.toxicon.2013.05.011_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1590\/S0034-70942009000300013","article-title":"Botulinum toxin in pain treatment","volume":"59","author":"Colhado","year":"2009","journal-title":"Rev. Bras. Anestesiol."},{"issue":"1\u20132","key":"10.1016\/j.toxicon.2013.05.011_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","article-title":"Pathophysiology of trigeminal neuralgia: the ignition hypothesis","volume":"18","author":"Devor","year":"2002","journal-title":"Clin. J. Pain"},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2011.11.001","article-title":"Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain","volume":"12","author":"Dolly","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X2005000100035","article-title":"Botulinum toxin: mechanisms of action","volume":"63","author":"Dressler","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1\u20133","key":"10.1016\/j.toxicon.2013.05.011_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2009.06.047","article-title":"Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models","volume":"617","author":"Favre-Guilmard","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.toxicon.2013.05.011_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199604253341709","article-title":"Treatment of trigeminal neuralgia","volume":"334","author":"Fields","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.toxicon.2013.05.011_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0021-5155(99)00197-5","article-title":"Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles","volume":"44","author":"Ishikawa","year":"2000","journal-title":"Jpn. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.toxicon.2013.05.011_bib22","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.pain.2011.07.019","article-title":"Forebrain medial septum region facilitates nociception in a rat formalin model of inflammatory pain","volume":"152","author":"Lee","year":"2011","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.toxicon.2013.05.011_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pbb.2007.12.001","article-title":"Sex differences in NMDA antagonist enhancement of morphine antihyperalgesia in a capsaicin model of persistent pain: comparisons to two models of acute pain","volume":"89","author":"Lomas","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.toxicon.2013.05.011_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.toxicon.2013.05.011_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clineuro.2010.02.004","article-title":"Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine","volume":"112","author":"Magalh\u00e3es","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.toxicon.2013.05.011_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1054\/jocn.2000.0684","article-title":"The current use of botulinum toxin","volume":"7","author":"Mahant","year":"2000","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.toxicon.2013.05.011_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2010.08.067","article-title":"Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models","volume":"171","author":"Marinelli","year":"2010","journal-title":"Neuroscience"},{"issue":"7428","key":"10.1016\/j.toxicon.2013.05.011_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.327.7428.1360","article-title":"Treatment options for trigeminal neuralgia","volume":"327","author":"Merrison","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.toxicon.2013.05.011_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.toxicon.2013.05.011_bib30","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","article-title":"Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain","volume":"109","author":"Ngeow","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"8","key":"10.1016\/j.toxicon.2013.05.011_bib31","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","article-title":"An open study of botulinum-A toxin treatment of trigeminal neuralgia","volume":"65","author":"Piovesan","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.toxicon.2013.05.011_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ACO.0b013e32833c3405","article-title":"The role of botulinum toxin in management of pain: an evidence-based review","volume":"23","author":"Qerama","year":"2010","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.05.011_bib33","first-page":"I12","article-title":"Botulinum toxin in tension-type headache","volume":"251","author":"Relja","year":"2004","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.toxicon.2013.05.011_bib34","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1526-4637.2010.00929.x","article-title":"Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases","volume":"11","author":"Safarpour","year":"2010","journal-title":"Pain Med."},{"issue":"3","key":"10.1016\/j.toxicon.2013.05.011_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcm.2010.04.004","article-title":"Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report","volume":"9","author":"Santamato","year":"2010","journal-title":"J. Chiropr. Med."},{"issue":"3","key":"10.1016\/j.toxicon.2013.05.011_bib36","first-page":"155","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.toxicon.2013.05.011_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jbspin.2008.05.006","article-title":"Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: a report of two cases","volume":"76","author":"Singh","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.toxicon.2013.05.011_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0896-6273(04)00077-7","article-title":"SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization","volume":"41","author":"Verderio","year":"2004","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.toxicon.2013.05.011_bib39","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1074\/jbc.M110.181784","article-title":"A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101011300192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101011300192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T17:11:06Z","timestamp":1595869866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101011300192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"alternative-id":["S004101011300192X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.05.011","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A closer look to botulinum neurotoxin type A-induced analgesia","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}